Stockscreener 앱 받기
6.41
1.26%
0.08
Relmada Therapeutics Inc 주식(RLMD)의 최신 뉴스
RLMDRelmada Therapeutics Inc Options - Finviz
Relmada's cancer drug candidate sparks fresh bullish call - MSN
RELMADA THERAPEUTICS INC (RLMD) Stock Chart - ChartMill
Enterprise value to EBITDA forward of Relmada Therapeutics, Inc. – NASDAQ:RLMD - TradingView
Enterprise value to revenue forward of Relmada Therapeutics, Inc. – NASDAQ:RLMD - TradingView
Price to book forward of Relmada Therapeutics, Inc. – NASDAQ:RLMD - TradingView
Relmada Therapeutics, Inc.(NasdaqCM:RLMD) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
Relmada Therapeutics, Inc.(NasdaqCM: RLMD) added to Russell 2500 Growth Benchmark - marketscreener.com
Relmada Therapeutics Joins Russell 2000, Russell 3000 Indexes - marketscreener.com
Relmada Therapeutics, Inc.(NasdaqCM: RLMD) added to Russell 2000 Index - marketscreener.com
Relmada Therapeutics added to Russell 2000 and 3000 indexes - Investing.com
Relmada Therapeutics added to Russell 2000 and 3000 indexes By Investing.com - Investing.com Australia
Relmada Therapeutics (RLMD) Joins Russell 2000 and 3000 Indices - GuruFocus
Relmada lands in Russell 2000 and Russell 3000 after reconstitution - Stock Titan
Relmada Therapeutics, Inc.(NasdaqCM: RLMD) added to Russell 2000 Growth Benchmark - marketscreener.com
Price to earnings forward of Relmada Therapeutics, Inc. – NASDAQ:RLMD - TradingView
Relmada Therapeutics, Inc.(NasdaqCM: RLMD) added to Russell 3000E Index - marketscreener.com
Price to sales forward of Relmada Therapeutics, Inc. – NASDAQ:RLMD - TradingView
Relmada Therapeutics, Inc.(NasdaqCM: RLMD) added to Russell Microcap Index - marketscreener.com
Relmada Therapeutics, Inc.(NasdaqCM: RLMD) added to Russell 3000 Index - marketscreener.com
RLMD Jumps As HC Wainwright Launches Buy Coverage - timothysykes.com
RLMD Jumps As H.C. Wainwright Launches Bullish Coverage - timothysykes.com
Relmada Therapeutics Inc Actuals & Estimates (NASDAQ:RLMD) - TradingView
RLMD Forecast — Price Target — Prediction for 2027 - TradingView
4E2 Forecast — Price Target — Prediction for 2027 - TradingView
Relmada Therapeutics (RLMD) Short Interest & Short Float | Updated Jun 2026 - MarketBeat
Relmada Therapeutics Inc (RLMD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Relmada Therapeutics Inc (NASDAQ: RLMD) Share Price, RLMD Stock News, RLMD Share Price & Updates - Kalkine
Relmada Therapeutics stock maintained at Buy by H.C. Wainwright - Investing.com
H.C. Wainwright Maintains Relmada Therapeutics(RLMD.US) With Buy Rating, Maintains Target Price $12 - Moomoo
H.C. Wainwright Reiterates Buy Rating on Relmada Therapeutics Inc (RLMD) - StreetInsider
Form 13G Relmada Therapeutics For: 22 June By Investing.com - Investing.com Australia
Millennium Group reports 4.57M Relmada shares (NASDAQ: RLMD) in 13G - Stock Titan
RLMD Q1 2026 Earnings: Wider-than-Expected Loss Amid Ongoing Clinical DevelopmentMargin Guidance - dars.gov.et
Relmada Therapeutics, Inc.(NasdaqCM:RLMD) added to S&P Pharmaceuticals Select Industry Index - marketscreener.com
Relmada: NDV-01 Entering Phase 3 In NMIBC, But There's No Rush To Buy Stock Today - Seeking Alpha
Relmada Therapeutics Inc (RLMD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Relmada Therapeutics (RLMD): 10 Best Growth Stocks Under $30 to Buy Now - Insider Monkey
RLMD News | RELMADA THERAPEUTICS INC (NASDAQ:RLMD) - ChartMill
RLMD Initiates Coverage On by HC Wainwright & Co. -- Rating Set to Buy - GuruFocus
Relmada's Cancer Drug Candidate Sparks Fresh Bullish Call - Benzinga
H.C. Wainwright initiates Relmada stock coverage with buy rating By Investing.com - Investing.com South Africa
H.C. Wainwright initiates Relmada stock coverage with buy rating - Investing.com
H.C. Wainwright Initiates Relmada Therapeutics(RLMD.US) With Buy Rating, Announces Target Price $12 - Moomoo
H.C. Wainwright Starts Relmada Therapeutics Inc (RLMD) at Buy, PT $12 - StreetInsider
10 Best Growth Stocks Under $30 to Buy Now - Insider Monkey
Relmada Therapeutics Inc (RLMD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Relmada Therapeutics Inc (RLMD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Relmada Therapeutics Inc (RLMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Relmada Therapeutics Inc (RLMD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Relmada Therapeutics Inc (RLMD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Relmada Therapeutics Inc (RLMD) Institutional Confidence - TradingKey
Relmada Therapeutics Inc (RLMD) Valuation: PE, PB & Fair Value Analysis - TradingKey
1.17%
2.48%
자본화:
|
볼륨(24시간):